NAS:BBH

VANECK ETF TR

$ 163.2279 2.6413 ( +1.64%) 12:35 PM EST
PE Ratio:
61.91
PB Ratio:
5.15
Volume:
4.39K
Dividend Yield %:
0.77
Last Holding update 2025-06-23 25 Stocks (1 new)
Value $366.00 Mil Turnover 4 %
Top Holdings: AMGN(16.46%) GILD(12.64%) VRTX(11.12%) REGN(5.21%) ARGX(5.16%)
Portfolio Report
Registrant: VanEck Biotech ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

VANECK ETF TR Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

VANECK ETF TR Key Statistics

Name Value
Day's Open ($) 162.62
Day's Range ($) 161.69 - 163.2808
Day's Volume 4,395
52-Week Range ($) 135.34 - 183.64
Beta 0.78
3-Year Sharpe Ratio -0.06
3-Year Sortino Ratio -0.08
Volatility 14.16
14-Day RSI 60.52
14-Day ATR ($) 2.483192
20-Day SMA ($) 156.40182

Fundamental Data

Name Value
Market Cap (Mil $) 350.303
Shares Outstanding (Mil) 2.15
PE Ratio 61.91
PE Ratio (10y Range) 13 - 60.92
PE Ratio (10y Median) 22.2
PB Ratio 5.15
PB Ratio (10y Range) 3.4 - 8.26
PB Ratio (10y Median) 4.95

Dividend Data

Name Value
Dividends per Share (TTM) ($) 1.252
Dividend Yield % 0.77
Dividend Yield % (10y Range) 0.21 - 0.89
Dividend Yield % (10y Median) 0.36
Next Dividend Payment Date
Dividend Frequency Annually

BBH VANECK ETF TR Fundamental Charts

Historical TTM Price-to-Earnings for BBH VANECK ETF TR

Historical TTM Price-to-Earnings without NRI for BBH VANECK ETF TR

Historical Price-to-Book Ratio for BBH VANECK ETF TR

Historical Dividend Yields for BBH VANECK ETF TR

VANECK ETF TR Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with NAS:BBH

No Available Data

NAS:BBH is held by these investors

No Available Data
VanEck Biotech ETF Top Holdings of 2025-03-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
AMGN
Amgen Inc
193,343
60,236.0
-18.05%
16.460
-2.80%
0.040
+11.60%
+19.96%
165,307.0
Drug Manufacturers
GILD
Gilead Sciences Inc
412,822
46,256.7
-18.06%
12.640
-2.12%
0.030
+6.72%
+23.77%
140,221.9
Drug Manufacturers
VRTX
Vertex Pharmaceuticals Inc
83,907
40,679.8
-18.23%
11.120
-1.90%
0.030
-3.12%
+18.47%
122,512.8
Biotechnology
REGN
Regeneron Pharmaceuticals Inc
30,038
19,051.0
-18.42%
5.210
-1.22%
0.030
-1.98%
-19.01%
62,117.4
Biotechnology
ARGX
argenx SE
31,891
18,875.2
-7.28%
5.160
-0.39%
0.050
-4.10%
-7.28%
34,786.0
Biotechnology
NTRA
Natera Inc
115,349
16,311.5
+3.25%
4.460
+0.14%
0.080
-7.11%
-12.82%
18,843.4
Medical Diagnostics & Research
ALNY
Alnylam Pharmaceuticals Inc
59,779
16,141.5
-5.80%
4.410
-0.22%
0.050
+35.36%
+39.20%
42,707.4
Biotechnology
IQV
IQVIA Holdings Inc
91,553
16,140.8
-1.85%
4.410
-0.09%
0.050
+30.81%
-2.11%
32,702.9
Medical Diagnostics & Research
ICLR
Icon PLC
74,581
13,050.9
+8.01%
3.570
+0.26%
0.090
+16.98%
-20.17%
13,306.8
Medical Diagnostics & Research
BIIB
Biogen Inc
91,100
12,466.1
+2.47%
3.410
+0.08%
0.060
+10.33%
-14.74%
19,104.3
Drug Manufacturers

VanEck Biotech ETF's Historical Top Holdings Breakdowns

VanEck Biotech ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
ITCI Unlock Delisted
Intra-Cellular Therapies Inc
2025-03-31
New Buy
New Buy
+2.89%
●
81.78 ($124.62) 131.92
$131.87
5.82%
New holding
80,052
80,052
AMGN
Amgen Inc
2025-03-31
Reduce
Reduce
-2.80%
●
258.59 ($295.3) 327.36
$307.43
4.11%
Reduce -18.05%
193,343
-42,572
GILD
Gilead Sciences Inc
2025-03-31
Reduce
Reduce
-2.12%
●
89.14 ($103.18) 117.41
$112.72
9.25%
Reduce -18.06%
412,822
-90,964
VRTX
Vertex Pharmaceuticals Inc
2025-03-31
Reduce
Reduce
-1.90%
●
402.49 ($466) 513.76
$477.08
2.38%
Reduce -18.23%
83,907
-18,709
REGN
Regeneron Pharmaceuticals Inc
2025-03-31
Reduce
Reduce
-1.22%
●
634.14 ($687.82) 744.83
$575.35
-16.35%
Reduce -18.42%
30,038
-6,784
CYTK
Cytokinetics Inc
2025-03-31
Sold Out
Sold Out
-0.65%
●
40.19 ($45.96) 51.12
$37.85
-17.63%
Sold Out
0
-54,580
ONC
BeOne Medicines Ltd
2025-03-31
Reduce
Reduce
-0.41%
●
175.1 ($233.79) 278.38
$295.47
26.38%
Reduce -22.84%
29,603
-8,764
ARGX
argenx SE
2025-03-31
Reduce
Reduce
-0.39%
●
571 ($631.12) 671.75
$570.25
-9.64%
Reduce -7.28%
31,891
-2,505
QGEN
Qiagen NV
2025-03-31
Reduce
Reduce
-0.29%
●
37.82 ($42.07) 48.86
$50.45
19.92%
Reduce -15.43%
137,668
-25,127
ICLR
Icon PLC
2025-03-31
Add
Add
+0.26%
●
174.99 ($193.87) 222.58
$167.41
-13.65%
Add 8.01%
74,581
5,528

VanEck Biotech ETF Total Holding History ($B)

To

VanEck Biotech ETF's Asset Allocation

To

VanEck Biotech ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

VanEck Biotech ETF's Hypothetical Growth since 2025-03-31

VanEck Biotech ETF's Yearly Returns

Year Portfolio % % Excess Gain %

VanEck Biotech ETF's Holdings Heat Map

Size field:

VanEck Biotech ETF's Holdings Bubble Chart

VanEck Biotech ETF News

  • 1

Discussions on VANECK ETF TR

User's Avatar
How would you rate this stock? BBH
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.